CLEO Diagnostics Ltd (AU:COV) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cleo Diagnostics Ltd has announced their Annual General Meeting (AGM) for shareholders, scheduled for 10:30 am on November 27, 2024, at FB Rice’s Melbourne offices. Shareholders will review the company’s Annual Report for the fiscal year ending June 30, 2024, and vote on key resolutions, including the adoption of the Remuneration Report and the re-election of Director Adrien Wing.
For further insights into AU:COV stock, check out TipRanks’ Stock Analysis page.